JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hahnenkamp, K.
Right arrow Articles by Linck, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hahnenkamp, K.
Right arrow Articles by Linck, B.
Related Collections
Right arrow Mechanisms
Right arrow Pharmacology

Anesth Analg 2004;99:416-422
© 2004 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000121351.38401.AB


ANESTHETIC PHARMACOLOGY

Modulation of Xenopus laevis Ca-Activated Cl Currents by Protein Kinase C and Protein Phosphatases: Implications for Studies of Anesthetic Mechanisms

Klaus Hahnenkamp, MD*, Marcel E. Durieux, MD PhD*, Hugo van Aken, MD PhD*, Sascha Berning*, Thomas J. Heyse*, Christian W. Hönemann, MD*, and Bettina Linck, MD PhD{dagger}

*Department of Anesthesiology and Intensive Care, and {dagger}Institute of Pharmacology and Toxicology, University Hospital, Muenster, Germany

Address correspondence to Marcel E. Durieux, MD, PhD, Department of Anesthesiology, University of Virginia, PO Box 800710, Charlottesville, VA 22908–0710. Address email to durieux{at}virginia.edu


    Abstract
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Ca-activated Cl currents (ICl(Ca)) are used frequently as reporters in functional studies of anesthetic effects on G protein-coupled receptors using Xenopus laevis oocytes. However, because anesthetics affect protein kinase C (PKC), they could indirectly affect ICl(Ca) if this current is regulated by phosphorylation. We therefore studied the effect of modulation of either PKC or protein phosphatases PP1{alpha} and PP2A on ICl(Ca) stimulated either by lysophosphatidate (LPA) signaling or by microinjection of Ca. X. laevis oocytes were studied under voltage clamp. Rat PP1{alpha} and PP2A were overexpressed in oocytes. PP, inositoltrisphosphate (IP3), the PP inhibitor okadaic acid (OA), the PKC inhibitor chelerythrine, or CaCl2 were directly injected into the oocyte. Responses to agonists (LPA 10–6 M, IP3 10–4 M, CaCl2 0.5 M) were measured at a holding potential of –70 mV in the presence or absence of the PP inhibitors cantharidin or OA. PP1 {alpha} and PP2A inhibited ICl(Ca) from 7.6 ± 0.9 µC to 2.5 ± 0.9 µC and 3.2 ± 1.4 µC, respectively. PP inhibition enhanced ICl(Ca) in control oocytes and reversed the inhibitory effect in oocytes expressing PP1 {alpha} or PP2A. PKC inhibition by chelerythrine enhanced both LPA- and CaCl2-induced ICl(Ca). Our data indicate that the Xenopus ICl(Ca) is modulated by phosphorylation. This may complicate design and interpretation of studies of G protein-coupled receptors using this model.

IMPLICATIONS: The Xenopus ICl(Ca), commonly used as a reporter current in studies of anesthetic effects on G protein-coupled signaling, is modulated by phosphorylation. Anesthetic effects on channel phosphorylation state can therefore be misinterpreted as effects on receptor signaling.


    Introduction
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Oocytes of the frog Xenopus laevis have become a commonly used model for the study of anesthetic effects on G protein-coupled receptors (GPCR). Particularly receptors that couple to Gq/11/14 proteins, which induce intracellular Ca release, are easily investigated in this model (1,2), as an endogenous Ca-activated Cl current (ICl(Ca)) provides a convenient end-point assay of changes in intracellular Ca concentration.

Anesthetics could potentially affect ICl(Ca) directly, and such interactions of the anesthetic with the reporter channel could be misinterpreted as interactions with the receptor signaling pathway. To exclude such an action, it has generally been considered sufficient to demonstrate that anesthetics do not affect ICl(Ca) induced by a receptor-independent increase in intracellular Ca concentrations (e.g., by microinjection of CaCl2). For many anesthetics (general as well as local) a lack of effect on receptor-independent ICl(Ca) has been demonstrated. However, we suggest that this may not be sufficient evidence to exclude anesthetic modulation of ICl(Ca). Activation of Gq/11/14-coupled receptors will, in addition to increasing intracellular Ca levels, result in generation of diacylglycerol (DAG), which will activate protein kinase C (PKC). If PKC were to regulate ICl(Ca) by channel phosphorylation, an effect of anesthetics on PKC activity could be misinterpreted as an effect on receptor signaling. Importantly, receptor-independent ICl(Ca) would not be affected by anesthetic in this scenario. In addition to affecting PKC, anesthetics might interact with protein phosphatases (PP), which dephosphorylate targets of PKC. This might also result in effects on ICl(Ca) that could be misinterpreted as actions on receptor signaling.

We hypothesized that the X. laevis ICl(Ca) is modulated by PKC and/or PP. To test this hypothesis, we investigated the effects of activation and inhibition of PKC, as well as overexpression and inhibition of PP, on receptor-, inositoltrisphosphate (IP3)-, or Ca-induced ICl(Ca) in Xenopus oocytes.


    Methods
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Isolation of X. laevis Oocytes
The study protocol was approved by the local Animal Care and Use Committee. Xenopus oocytes were removed as described previously (3). In brief, frogs were anesthetized by immersion in cold 0.2% 3-amino-benzoic-methyl-ester until fully immobile. After abdominal incision an ovarian lobule, containing approximately 200 cells, was removed under sterile conditions. The frogs were allowed to recover from anesthesia and operation in a separate tank. Oocytes were maintained at 20°C in modified Barth’s solution (containing 88 mM NaCl, 2.4 mM NaHCO3, 0.41 mM CaCl2, 0.82 mM MgSO4, 0.3 mM Ca2NO3, 0.1 mM gentamycin, and 15 mM HEPES, pH adjusted to 7.4). Oocytes were defolliculated by gentle shaking in 1 mg/mL solution of collagenase type A in calcium-free OR2 solution (containing 82.5 mM NaCl, 2 mM KCl, 1 mM MgCl2, and 5 mM HEPES, pH adjusted to 7.4). After 2 h the cells were returned to modified Barth’s solution. Microscopic observation confirmed that the follicle cells had been removed.

PP Overexpression
The plasmids with cDNA inserts for the catalytic subunit of rat PP1{alpha} and PP2A were obtained by large-scale preparations. Inserts were isolated by digestion with XbaI and BamHI for PP1{alpha} and with PstI and EcoRI for PP2A. The cDNA inserts were purified from 1% agarose gels. Sizes were approximately 1000 bp for PP1{alpha} and 1300 bp for PP2A. Oocytes were injected with 10 ng cDNA in 50.6 nL sterile water using an automated microinjector (Nanoject; Drummond Scientific, Broomall, PA). The area of the germinal vesicle was targeted, and sufficient injection was confirmed by noting a slight increase in cell size. The cells were then cultured in modified Barth’s solution for 72 h to allow time for expression of the corresponding PP.

Electrophysiology
A single defolliculated cell was positioned in a continuous-flow chamber with 0.5 mL volume, perfused (5 mL/min) by Tyrode’s solution (containing 150 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgSO4, 10 mM dextrose, and 10 mM HEPES, pH adjusted to 7.4). Microelectrodes were pulled in one stage from capillary glass on a vertical computer-controlled electrode puller (Sutter Instrument Company, Novato, CA). Electrode tips were broken to a diameter of approximately 10 µm, providing a resistance of 1–3 M{Omega}, and filled with 3 M KCl. The oocytes were voltage clamped using a two-electrode voltage clamp amplifier (OC725C; Warner Instruments Corp., New Haven, CT) connected to an IBM-compatible personal computer for data acquisition and analysis (software by J. Kardeous, PhD, University of Muenster, Germany). All measurements were performed at a holding potential of –70 mV. We sampled membrane current at 125 Hz and recorded during 5 s before and 85 s after drug administration. This allowed sufficient time for currents to return to baseline levels. Responses were quantified by integrating the current trace and reported in µC. All experiments were performed at room temperature.

Receptor agonist (lysophosphatidate, LPA) was delivered as a 30 µL aliquot (Tyrode’s solution containing 0.1% fatty acid free bovine serum albumin [BSA]) over a period of 2 s using a hand-held micropipette positioned approximately 2 mm in front of the oocyte.

Intracellular Microinjection
PP, IP3, CaCl2, or the PP inhibitor okadaic acid (OA) were diluted in 150 mM of KCl and applied by direct injection into the oocyte using a third electrode inserted into the oocyte. This electrode was connected to an automated microinjector (Nanoject, Drummond Scientific). Under voltage clamp condition, 50.6 nL of 10–4 M IP3, 0.5 M CaCl2, or OA (10–9 M or 10–5 M) were injected. The volume of a Xenopus oocyte is approximately 500 nL; therefore we injected an additional volume of approximately 10%. The final concentration of the administered drug was estimated from these numbers, but it should be taken into account that distribution inside the cell will not be homogeneous. Injection of 50.6 nL KCl 150 mM was used as control. To inhibit PKC, 50 nL of 5 x 10–4 M chelerythrine diluted in 150 mM KCl (or 150 mM KCl as control) was microinjected into oocytes 2 h before experiments; estimated final concentration was 50 µM.

PP Assay
Assays for protein phosphatase activity were performed as described previously (4), using [32P]-phosphorylase a as substrate. The incubation mixture contained 5 mM caffeine, 0.1% (v/v) ß-mercaptoethanol, 0.1 mM EDTA, and 20 mM Tris HCl (pH 7.0). The reaction was started by adding aliquots of homogenates and terminated after 10 min by the addition of 50% trichloroacetic acid. Precipitated protein was sedimented by centrifugation and the supernatant counted in a liquid scintillation counter.

Data Analysis
Unless stated otherwise, all results are reported as mean ± SEM. Differences among treatment groups were analyzed using Student’s t-test or Mann-Whitney U-test. If multiple comparisons were made, analysis of variance was conducted, followed by Student’s t-test corrected for multiple comparisons (Bonferroni). P < 0.05 was considered significant. Concentration-response curves were fit to the following logistic function, derived from the Hill equation:


where ymax and ymin are the maximum and minimum response obtained, n is the Hill coefficient, and x50 is the half-maximal effect concentration/half-maximal inhibitory effect (EC50 for agonist/IC50 for antagonist).

Materials
LPA was obtained from Avanti Polar Lipids (Alabaster, AL) and was diluted in 0.1% fatty acid-free BSA (ICN Pharmaceuticals, Costa Mesa, CA) in Tyrode’s solution to the appropriate concentration. Cantharidin, OA, and IP3 were obtained from Sigma Aldrich Chemie GmbH (Steinheim, Germany). Collagenase A was acquired from Boehringer Mannheim GmbH (Mannheim, Germany).


    Results
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
PKC Modulates ICl(Ca)
The phospholipid LPA induces ICl(Ca) by activating an endogenous receptor in the oocyte and was used in this investigation as a method for inducing receptor-mediated ICl(Ca). We demonstrated previously that LPA signaling in oocytes is modulated by PKC (2). We now compared the effect of altering PKC activity on LPA-induced ICl(Ca) with its effect on receptor-independent activation of ICl(Ca) by intracellular injection of CA.

LPA induced transient ICl(Ca), as described previously. EC50 was calculated from the concentration-response relationship and was 5.4 ± 0.2 x 10–7 M (Fig. 1A). A concentration of 10–6 M was used for all subsequent experiments.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 1. A, lysophosphatidic acid (LPA) signaling in Xenopus laevis oocytes. LPA activates the ICl(Ca) in a concentration-dependent manner. n ≥ 7 for each data point. B, effects of 2 h intracellular protein kinase C (PKC) inhibition with 5 x 10–4 M chelerythrine on lysophosphatidic acid (LPA) signaling. Inhibition of PKC-enhanced (LPA 10–6 M) responses by 65%. ICl(Ca) induced by intracellular injection of CaCl2 (CaCl2 ic)) as similarly enhanced in the presence of chelerythrine (91%), indicating that ICl(Ca) is modulated by phosphorylation by PKC. *P < 0.05. Values are mean ± SEM. n ≥ 7.

 
Inhibition of PKC with the antagonist chelerythrine enhanced LPA responses by 65% (Fig. 1B). These findings are comparable with those reported previously (2). Receptor-independent ICl(Ca), induced by intracellular injection of Ca, was enhanced in the presence of chelerythrine (91%, Fig. 1B). This finding indicates that ICl(Ca) is modulated by PKC activity.

PP Overexpression Modulates LPA-Induced ICl(Ca)
To study the effects of PP on ICl(Ca), we overexpressed PP1{alpha} or PP2A in oocytes. To assure functional expression, we determined phosphatase activity in cells overexpressing PP. Injection of either PP1{alpha} or PP2A resulted in an approximate twofold increase in PP activity compared with KCl-injected control oocytes (Fig. 2A), confirming that the overexpressed proteins were functional. In cells overexpressing PP, LPA-induced ICl(Ca) was diminished as compared with control oocytes (Fig. 2B). The currents declined by 67% in PP1{alpha}-injected oocytes and by 58% in PP2A injected cells. To confirm that this inhibitory effect was specific, we also determined the effect of injection of purified PP1{alpha} protein (Fig. 2C). The injection of purified PP1{alpha} protein also reduced the LPA-induced ICl(Ca) as compared with KCl-injected control cells, suggesting that the inhibitory effect is most likely a direct result of PP activity. In PP1{alpha}-injected oocytes, the relatively nonselective PP inhibitor cantharidine (10–5 M) abolished the inhibitory effect of PP overexpression on LPA-induced ICl(Ca) (Fig. 3A). OA 10–5 M also abolished the inhibitory effect of PP1{alpha} overexpression on LPA-induced ICl(Ca) (Fig. 3A). Similar results were obtained in PP2A-injected oocytes (Fig. 3B). Therefore, receptor-mediated ICl(Ca) can be modulated by PP.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 2. A, protein phosphatase activity in preparations from oocytes overexpressing protein phosphatase 1{alpha} (PP1{alpha}) and protein phosphatase 2A (PP2A) in comparison with KCl-injected oocytes (control). Phosphatase activity was measured as described in Methods. *P < 0.05, n = 3. B, effects of protein phosphatase 1{alpha} (PP1{alpha}) and protein phosphatase 2A (PP2A) on lysophosphatidic acid (LPA)-induced (10–6 M) ICl(Ca). ICl(Ca) were inhibited in oocytes expressing PP1{alpha} or PP2A compared with control. There was no difference between control and KCl-injected cells. *P < 0.05. Values are mean ± SEM. n ≥ 7. C, effect of protein injection compared with cDNA injection of protein phosphatase 1{alpha} (PP1{alpha}) in Xenopus oocytes. The injection of purified PP1{alpha} protein also reduced the LPA-induced ICl(Ca) as compared with KCl-injected control cells. *P < 0.05. Values are mean ± SEM. n > 7.

 


View larger version (15K):
[in this window]
[in a new window]
 
Figure 3. Effects of the protein phosphatase (PP) inhibitors cantharidine (Cant, 10–5 M) and okadaic acid (OA, 10–5 M) on native oocytes and protein phosphatase (PP) injected oocytes. A, PP1{alpha} overexpression inhibited lysophosphatidic acid (LPA)-induced ICl(Ca) responses compared with KCl injected oocytes (KClic). The PP inhibitors Cant and OA abolished the inhibitory effect of PP1{alpha} overexpression (values are mean ± SEM, n ≥ 7, n ≥ 3 for experiments with OA, *P < 0.05 versus PP1 {alpha}, #P < 0.05 PP1{alpha} versus KClic). B, in PP2A overexpressing oocytes Cant and OA abolished the inhibitory effect of PP overexpression (values are mean ± SEM, n ≥ 7, n ≥ 3 for experiments with okadaic acid, *P < 0.05 versus PP2A, #P < 0.05 PP2A versus KClic). C, the PP inhibitors Cant and OA increased LPA-induced ICl(Ca) in KCl-injected oocytes (control(KClic)), suggesting the presence of endogenous PP in Xenopus laevis oocytes. Values are mean ± SEM, n ≥ 7, n ≥ 3 for experiments with okadaic acid, *P < 0.05 versus control(KClic).

 
Endogenous PP Modulate LPA-Induced ICl(Ca)
As overexpression of PP inhibits LPA-induced ICl(Ca), it appears conceivable that endogenous oocyte PP might similarly affect this pathway. To test this hypothesis and to exclude potential artifactual effects resulting from overexpression of PP, we determined the effect of PP inhibitors on LPA-induced ICl(Ca). Cantharidin (10–5 M) increased LPA-induced ICl(Ca) in KCl-injected oocytes (Fig. 3C), suggesting the presence of endogenous PP in X. laevis oocytes and that LPA signaling is regulated by activity of these PP. OA (10–5 M) similarly increased LPA-induced ICl(Ca) in control oocytes (Fig. 3C)

Endogenous PP Modulate IP3- or Ca-Induced ICl(Ca)
To delineate the site of action of endogenous PP on ICl(Ca), we next determined if ICl(Ca) induced by either IP3 or CaCl2 would be affected by PP also. Both IP3 and CaCl2 elicited ICl(Ca) when injected directly into oocytes (Fig. 4A and 4B). In cells overexpressing PP1{alpha} or PP2A, ICl(Ca) induced by IP3 (10–4 M) was reduced by 46% or 71%, respectively. Responses to CaCl2 (0.5 M) were reduced by 63% or 75% in cells expressing PP1{alpha}) or PP2A, respectively. These results demonstrate that the effects of PP do not take place in the LPA signaling pathway but are most likely mediated by alteration of the phosphorylation state of the Ca-activated Cl channel.



View larger version (14K):
[in this window]
[in a new window]
 
Figure 4. Effects of inositoltrisphosphate (IP3) and CaCl2 on ICl(Ca) in protein phosphatase 1{alpha} (PP1A) or protein phosphatase 2A (PP2A) injected oocytes compared with control (KCl-injected oocytes). A, ICl(Ca) generated by the injection of 100 µM IP3 were inhibited in PP1{alpha} or PP2A overexpressing oocytes compared with control (KCl-injected oocytes) (values are mean ± SEM, n ≥ 7, *P < 0.05 versus control). B, ICl(Ca) induced by the injection of 500 mM CaCl2 were inhibited in PP1{alpha} or PP2A overexpressing oocytes compared with control (KCl-injected oocytes) (values are mean ± SEM, n ≥ 7,*P < 0.05 versus control).

 

    Discussion
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
The main findings of the present study are that receptor-independent ICl(Ca) is modulated by both PKC and PP and that, interestingly, the targets of PP and PKC appear to be different. Whereas a decrease in phosphorylation state induced by inhibition of PKC enhances ICl(Ca), decreasing phosphorylation by overexpression of PP inhibits responses. This could imply that PKC phosphorylates different sites on the Cl channel than are dephosphorylated by PP and that these various sites have different functions. Alternatively, one (or both) of the enzymes could act indirectly, i.e., PKC could phosphorylate a protein that in turn modulates the Cl channel. Our data do not allow us to differentiate between these options but do indicate that the oocyte ICl(Ca) is a current heavily regulated by phosphorylation and dephosphorylation.

These findings are of relevance for studies of anesthetics on signaling systems using the Xenopus oocyte ICl(Ca) as reporter. In such studies, the target of interest is usually a G protein-coupled receptor expressed in oocytes by injection of complementary RNA or DNA. Such receptors couple effectively to endogenous Xenopus G proteins, and those receptors that activate Gq, G11 and/or G14 proteins will induce an IP3-mediated increase in intracellular Ca levels. This, in turn, will activate ICl(Ca). Whereas the expressed receptor is often of mammalian origin, and the G protein—phospholipase C—IP3 receptor pathway in oocytes has been shown to be functionally similar to its mammalian counterpart, the frog Ca-activated Cl channel is not a part of this signaling system in mammals. Thus, an anesthetic effect on ICl(Ca) would be of limited relevance, and it is therefore appropriate to assure that any anesthetic effects observed take place upstream of the Cl channel. To determine the anesthetic site of action, control experiments are often performed in which ICl(Ca) is activated by direct injection into the oocyte of either IP3 or Ca. If ICl(Ca) induced by this means is not affected by the anesthetic, this is taken to imply that the anesthetic is not affecting the Ca-activating Cl channel.

Our data suggest that this control experiment may not be sufficient. Activation of Ca-signaling G proteins also induces the release of DAG, which in turn will activate PKC. Our findings indicate that PKC activation by this means is likely to increase phosphorylation of the Cl channel, resulting in decreased currents. Many anesthetics, volatile as well as local, affect PKC (5,6). Interactions are complex and depend both on the specific anesthetic studied and the PKC subtypes present in the model under study. In Xenopus oocytes, it appears that at least some volatile anesthetics increase PKC activity. For example, halothane inhibits muscarinic signaling in this model (7), but this effect is abolished completely by pretreatment of the cells with PKC antagonists (8). In contrast, local anesthetics appear to inhibit PKC (9). If receptors are activated in the presence of anesthetic, PKC activity induced by receptor signaling will be modulated by the anesthetic, and ICl(Ca) will be altered. If, however, the channel is activated directly by injection of Ca, no PKC activation will occur, and ICl(Ca) will therefore not be modulated by the presence of anesthetics. Therefore, differences in ICl(Ca) measured in the presence and absence of anesthetic could be misinterpreted as an anesthetic effect on the proximal receptor signaling pathway.

A similar argument could be made for the role of PP. However, essentially nothing is known of the interactions between anesthetics and PP. We suggest that the appropriate control experiments would be to determine the effect of anesthetics on ICl(Ca) induced by receptor signaling or by Ca injection in the presence of PKC and PP inhibitors. Alternatively, a more proximal (and admittedly less convenient) end-point (e.g., IP3 production) could be used.

Our findings also have some implications for studies of receptor physiology in oocytes, as it is possible to misconstrue an effect of PKC on ICl(Ca) as an effect on the receptor. For example, we have shown previously that LPA signaling in oocytes is regulated by PKC: LPA signaling was affected by either PKC inhibition or activation (2). In view of the current findings, it can not be excluded that such effects on signaling are an action on the Cl channel, rather than on the LPA receptor. In this particular instance, however, this seems not to be the case. Kim et al. (1) also investigated PKC regulation of LPA signaling and observed that PKC activation not only abolished LPA-induced ICl(Ca) but also the increase in IP3 levels induced by LPA signaling. Conversely, inhibiting PKC enhanced IP3 production. This indicates that the role of PKC is indeed proximal in the signaling pathway.

The modulation of the Xenopus ICl(Ca) by channel phosphorylation has not been studied in detail. The effect appears to be somewhat specific to PKC, as Chen et al. (10) reported that protein kinase A is without effect on the Ca-activated Cl channel. They did observe an effect of increased cyclic adenosine monophosphate (cAMP) concentrations on ICl(Ca) but demonstrated that this action was indirect and occurred by enhancement of endogenous Ca currents. Of regulation by PP virtually nothing is known. Chen et al. (10) demonstrated previously that injection of PP 1 and 2A attenuated a cAMP-induced increase of ICl(Ca) (10), and our observations that inhibition of PP increases ICl(Ca) above baseline indicates that regulation of channel activity by PP occurs under basal conditions. However, we have not conclusively shown that it is the channel itself that is being directly phosphorylated and dephosphorylated. It is conceivable that the activity of another regulatory molecule would be modulated by phosphorylation, and in turn would regulate the channel.

In summary, we have demonstrated that the X. laevis oocyte ICl(Ca) is modulated by both PKC and PP. These findings should be taken into account in the interpretation of studies using ICl(Ca) as a reporter for determining effects of anesthetics on GPCR, as well as in the design of such studies.


    Acknowledgments
 
Supported, in part, by the Department of Anesthesiology and Critical Care, University Hospital, Muenster, Germany.


    References
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 

  1. Kim MJ, Lee YS, Han JK. Modulation of lysophosphatidic acid-induced Cl-currents by protein kinases A and C in the Xenopus oocyte. Biochem Pharmacol 2000; 59: 241–7.[Medline]
  2. Sullivan LM, Honemann CW, Arledge JA, Durieux ME. Synergistic inhibition of lysophosphatidic acid signaling by charged and uncharged local anesthetics. Anesth Analg 1999; 88: 1117–24.[Abstract/Free Full Text]
  3. Hoenemann CW, Heyse TJ, Möllhoff T, et al. The inhibitory effect of bupivacaine on prostaglandine E2 (EP1) receptor functioning: mechanism of action. Anesth Analg 2001; 93: 628–34.[Abstract/Free Full Text]
  4. Neumann J, Boknik P, Herzig S, et al. Evidence for physiological functions of protein phosphatases in the heart: evaluation with okadaic acid. Am J Physiol 1993; 265: H257–66.
  5. Do SH, Fang HY, Ham BM, Zuo ZY. The effects of lidocaine on the activity of glutamate transporter EAAT3: the role of protein kinase C and phosphatidylinositol 3-kinase. Anesth Analg 2002; 95: 1263–8.[Abstract/Free Full Text]
  6. Hollmann MW, Gross A, Jelacin N, Durieux ME. Local anesthetic effects on priming and activation of human neutrophils. Anesthesiology 2001; 95: 113–22.[Web of Science][Medline]
  7. Durieux ME. Halothane inhibits signaling through m1 muscarinic receptors expressed in Xenopus oocytes. Anesthesiology 1995; 82: 174–82.[Web of Science][Medline]
  8. Minami K, Vanderah TW, Minami M, Harris RA. Inhibitory effects of anesthetics and ethanol on muscarinic receptors expressed in Xenopus oocytes. Eur J Pharmacol 1997; 339: 237–44.[Web of Science][Medline]
  9. Schauerte SK, Hahnenkamp K, Struemper D, et al. Local anesthetics inhibit NMDA receptor signaling by inhibiting protein kinase [abstract]. Anesthesiology 2003; 89: A934.
  10. Chen Y, Pollock JD, Wang Y, et al. Protein kinase A modulates an endogenous calcium channel, but not the calcium-activated chloride channel, in Xenopus oocytes. FEBS Lett 1993; 336: 191–6.[Medline]
Accepted for publication January 22, 2004.





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hahnenkamp, K.
Right arrow Articles by Linck, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hahnenkamp, K.
Right arrow Articles by Linck, B.
Related Collections
Right arrow Mechanisms
Right arrow Pharmacology


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2004 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press